Home · Peptides · Ventfort
THE PEPTIDE APP FIELD GUIDE · Longevity SERIES FIELD SPECIMEN
Longevity CATEGORY

Ventfort

THE ARTERY RESTORER

A-16 Vascular Bioregulator Peptide

Ventfort is a bioregulator peptide derived from blood vessel tissue that helps restore the health of your arteries and veins. It works by enhancing nitric oxide production for better blood flow, promoting arterial elasticity, and reducing vascular inflammation. Ideal for people with cardiovascular risk factors or age-related circulation decline.

Ventfort
Ventfort
Ventfort

Ventfort Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

May 8, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Ventfort

◆

Is Ventfort FDA approved?

No. This profile records Ventfort as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Ventfort?

Dose: 20 mg orally each morning.

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Ventfort guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Nitric Oxide Enhancement

Upregulates eNOS for improved vasodilation and blood flow

Vascular Regeneration

Restores smooth muscle and extracellular matrix via TGF-β/SMAD signaling

Inflammation Reduction

Downregulates NF-κB and adhesion molecules (VCAM-1, ICAM-1)

People with cardiovascular risk factors
Those with poor circulation or cold extremities
Anyone with diabetes affecting blood vessels
People wanting to maintain vascular health during aging
Those recovering from vascular injury

Ventfort Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.